EUVIMEDEUVIMED entdecken
BeobachtungsstudieQuerschnittstudieOpen Access · CC BY 4.0

Clinical and Proteomic Associations of SARS-CoV-2 Infection and COVID-19 Vaccination in Multimorbid Patients: A Cross-Sectional Observational Study

Anett Hudák iD, Aladár Pettko-Szandtner, Annamária Letoha, Tamás Letoha iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26168007 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anett Hudák und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacoidea Ltd., H-6726 Szeged, Hungary. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, SARS-CoV-2, Proteome. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office, European Commission, Horizon Europe—Research Framework Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaccines played a crucial role in the COVID-19 pandemic, but their long-term biological effects and efficacy in vulnerable populations remain under intensive investigation. This study assessed clinical outcomes, comorbidities, and systemic biomarker and proteomic profiles in 366 multimorbid patients, stratified into four groups based on SARS-CoV-2 infection and vaccination status (COV+ vac+, COV+ vac−, COV− vac+, COV− vac−). Clinical and laboratory data, including comorbidities and relevant biomarkers, were collected. Proteomic analysis using mass spectrometry was performed to identify molecular changes associated with infection and vaccination. Statistical analyses examined associations between clinical status, biomarkers, and patient outcomes. As most participants received mRNA-based vaccines, the results primarily reflect responses to spike protein-expressing platforms. Biomarkers of cardiac and renal stress—namely proBNP and carbamide—were elevated in vaccinated individuals. Five deaths occurred in the COV+ vac+ group and two in the COV+ vac− group, most of which were attributed to exacerbations of pre-existing chronic diseases rather than to COVID-19 pneumonia. Protection against breakthrough infections waned over time, particularly beyond 200 days post-vaccination. Mass spectrometry identified proteins such as actin, fibrinogen chains, and SAA2 as potential diagnostic targets. Although the cross-sectional observational design limits the ability to draw causal inferences, the observed waning immunity and potential systemic alterations in vaccinated multimorbid patients highlight the importance of longitudinal follow-up to guide tailored immunization strategies and post-vaccination monitoring in high-risk groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesSARS-CoV-2ProteomeHumansMaleFemaleMiddle AgedCross-Sectional StudiesAgedProteomicsVaccinationBiomarkersMultimorbidityAdultAged, 80 and over

Stichwörter der Autor:innen

COVID-19biomarkersclinical outcomescomorbiditiesmass spectrometryproteomicsvaccinationvaccine safety and efficacy

Substanzen

COVID-19 VaccinesBiomarkersProteome

Autor:innen und Institutionen

  • Pharmacoidea Ltd., H-6726 Szeged, Hungary.
  • Biological Research Centre of the Hungarian Academy of Sciences, H-6726 Szeged, Hungary.
  • Albert Szent-Györgyi Clinical Center, Department of Medicine, Faculty of Medicine, University of Szeged, H-6720 Szeged, Hungary.

ORCID-Profile: Anett Hudák, Tamás Letoha

Förderung

  • National Research, Development and Innovation Office
  • European Commission
  • Horizon Europe—Research Framework Programme
  • Comorbidity Mechanisms Utilized In Healthcare (COMMUTE)

Zitieren

APA

Hudák, A., Pettko-Szandtner, A., Letoha, A., & Letoha, T. (2025). Clinical and Proteomic Associations of SARS-CoV-2 Infection and COVID-19 Vaccination in Multimorbid Patients: A Cross-Sectional Observational Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26168007

Vancouver

Hudák A, Pettko-Szandtner A, Letoha A, Letoha T. Clinical and Proteomic Associations of SARS-CoV-2 Infection and COVID-19 Vaccination in Multimorbid Patients: A Cross-Sectional Observational Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26168007

BibTeX
@article{Hudk2025,
  author = {Hudák, Anett and Pettko-Szandtner, Aladár and Letoha, Annamária and Letoha, Tamás},
  title = {Clinical and Proteomic Associations of SARS-CoV-2 Infection and COVID-19 Vaccination in Multimorbid Patients: A Cross-Sectional Observational Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26168007}
}
Kostenlos starten →